MRP/GST Synergy in MDR
MRP/GST Synergy in MDR
批准号:
7404439
负责人:
CHARLES S MORROW
金额:
$26.02万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-05-10 至 2010-04-30
关键词:
ABCC1 geneATP-Binding Cassette TransportersAffectAntineoplastic AgentsBiochemicalBiologicalCarcinogensCellsClassClinicDNADrug resistanceEnzymesFamilyGSTP1 geneGenetic VariationGlutathioneGoalsIsoenzymesLaboratoriesLigand BindingMeasurableMediatingMitoxantroneNuclear ReceptorsPatientsPharmaceutical PreparationsPilot ProjectsPopulationProcessPropertyProtein IsoformsProtein OverexpressionResistanceRoleTestingToxinTransferaseWorkXenobioticsbasecancer cellcancer preventioncytotoxicitydrug sensitivitygenotoxicityglutathione S-transferase pimemberneoplastic cellresponse
中文摘要
描述(由申请人提供):本实验室研究谷胱甘肽(GSH)、谷胱甘肽偶联过程和mrp介导的外排相互作用如何影响细胞对抗癌药物、致癌物和其他细胞毒素的敏感性。特别是,我们已经测试了GSH转移酶(GST)和MRP1-3协同作用以赋予对亲电毒素的抗性的假设。事实上,我们已经证明GST同工酶与MRP同工酶的联合表达可以抵抗一些亲电性癌症药物和致癌物的细胞毒性和基因毒性。基于这些和其他最近的结果,这些研究提出扩展GSH、GSH偶联和MRP相互作用调节细胞对外源药物的反应,这些反应与癌症的治疗和预防密切相关。提出了四个新的具体目标。
英文摘要
DESCRIPTION (provided by applicant): Work in this laboratory has examined how glutathione (GSH) and the processes of GSH conjugation and MRP-mediated efflux interact to influence the sensitivities of cells to anticancer drugs, carcinogens and other cellular toxins. In particular, we have tested the hypothesis that GSH transferases (GST) and MRP1-3 act in synergy to confer resistance to electrophilic toxins. Indeed, we have shown that combined expression of isozymes of GST with isoforms of MRP confers resistance to the cytotoxicities and genotoxicities of some electrophilic cancer drugs and carcinogens. Based upon these and other recent results, the studies proposed expand upon the theme that GSH, GSH-conjugation, and MRP interactions modulate cellular responses to xenobiotics-responses that are germane to the treatment and prevention of cancer. Four new specific aims are outlined.
1) Specific aim 1 applies to the clinic the results obtained from our previous cellular and biochemical studies. The long-term goal of these pilot studies is to test the hypothesis that combined overexpression of alpha class GST and MRP1 will adversely affect treatment response in patients with CLL. 2) Specific aim 2 examines the role of MRP1 and GSH in resistance to and transport of the anticancer drug mitoxantrone (MX). This aim is based upon preliminary studies suggesting that MX is a substrate of MRP1 with unique properties that distinguish its transport from that of other MRP1 substrates. 3) Specific aim 3 tests the hypothesis that the specific allelic variants of GSTP1 as well as the particular MRP isoform expressed are important determinants of cellular resistance to Pt-based anticancer drugs.
4) Specific aim 4 examines the hypothesis that, in a mixed population of tumor cells, cells that are drug resistant on the basis of expression of GST and MRP will influence the drug sensitivities of neighboring cells that do not express GST and MRP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MRP/GST SYNERGY IN MULTIDRUG RESISTANCE
-
批准号:6626658
-
项目类别:
-
资助金额:$23.77万
-
财政年份:1996
-
负责人:CHARLES S MORROW
-
依托单位:
MRP/GST SYNERGY AND MDR
-
批准号:2114246
-
项目类别:
-
资助金额:$12.24万
-
财政年份:1996
-
负责人:CHARLES S MORROW
-
依托单位:
MRP/GST SYNERGY IN MULTIDRUG RESISTANCE
-
批准号:6342007
-
项目类别:
-
资助金额:$22.52万
-
财政年份:1996
-
负责人:CHARLES S MORROW
-
依托单位:
MRP/GST SYNERGY IN MULTIDRUG RESISTANCE
-
批准号:6045386
-
项目类别:
-
资助金额:$25.44万
-
财政年份:1996
-
负责人:CHARLES S MORROW
-
依托单位:
MRP/GST Synergy in MDR
-
批准号:6965425
-
项目类别:
-
资助金额:$27.44万
-
财政年份:1996
-
负责人:CHARLES S MORROW
-
依托单位:
MRP/GST Synergy in MDR
-
批准号:7241542
-
项目类别:
-
资助金额:$26.02万
-
财政年份:1996
-
负责人:CHARLES S MORROW
-
依托单位:
MRP/GST SYNERGY AND MDR
-
批准号:2414451
-
项目类别:
-
资助金额:$13.17万
-
财政年份:1996
-
负责人:CHARLES S MORROW
-
依托单位:
MRP/GST SYNERGY IN MULTIDRUG RESISTANCE
-
批准号:6489238
-
项目类别:
-
资助金额:$23.11万
-
财政年份:1996
-
负责人:CHARLES S MORROW
-
依托单位:
MRP/GST SYNERGY IN MULTIDRUG RESISTANCE
-
批准号:6688931
-
项目类别:
-
资助金额:$24.48万
-
财政年份:1996
-
负责人:CHARLES S MORROW
-
依托单位:
MRP/GST Synergy in MDR
-
批准号:7069519
-
项目类别:
-
资助金额:$26.8万
-
财政年份:1996
-
负责人:CHARLES S MORROW
-
依托单位:
MRP/GST SYNERGY AND MDR
-
批准号:2700670
-
项目类别:
-
资助金额:$13.69万
-
财政年份:1996
-
负责人:CHARLES S MORROW
-
依托单位:
MDR1 PROMOTER--IN VIVO ACTIVITY AND CHROMATIN STRUCTURE
-
批准号:2733106
-
项目类别:
-
资助金额:$10.56万
-
财政年份:1994
-
负责人:CHARLES S MORROW
-
依托单位:
MDR1 PROMOTER--IN VIVO ACTIVITY AND CHROMATIN STRUCTURE
-
批准号:2107151
-
项目类别:
-
资助金额:$9.84万
-
财政年份:1994
-
负责人:CHARLES S MORROW
-
依托单位:
MDR1 PROMOTER--IN VIVO ACTIVITY AND CHROMATIN STRUCTURE
-
批准号:2443107
-
项目类别:
-
资助金额:$10.2万
-
财政年份:1994
-
负责人:CHARLES S MORROW
-
依托单位:
MDR1 PROMOTER--IN VIVO ACTIVITY AND CHROMATIN STRUCTURE
-
批准号:2107150
-
项目类别:
-
资助金额:$9.49万
-
财政年份:1994
-
负责人:CHARLES S MORROW
-
依托单位:
MDR1 PROMOTER--IN VIVO ACTIVITY AND CHROMATIN STRUCTURE
-
批准号:2107149
-
项目类别:
-
资助金额:$10.05万
-
财政年份:1994
-
负责人:CHARLES S MORROW
-
依托单位:
海外基金